Unknown

Dataset Information

0

TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.


ABSTRACT: RIG-I-MAVS antiviral signaling represents an important pathway to stimulate interferon production and confer innate immunity to the host. Upon binding to viral RNA and Riplet-mediated polyubiquitination, RIG-I promotes prion-like aggregation and activation of MAVS. MAVS subsequently induces interferon production by activating two signaling pathways mediated by TBK1-IRF3 and IKK-NF-?B respectively. However, the mechanism underlying the activation of MAVS downstream pathways remains elusive. Here, we demonstrated that activation of TBK1-IRF3 by MAVS-Region III depends on its multimerization state and identified TRAF3IP3 as a critical regulator for the downstream signaling. In response to virus infection, TRAF3IP3 is accumulated on mitochondria and thereby facilitates the recruitment of TRAF3 to MAVS for TBK1-IRF3 activation. Traf3ip3-deficient mice demonstrated a severely compromised potential to induce interferon production and were vulnerable to RNA virus infection. Our findings uncover that TRAF3IP3 is an important regulator for RIG-I-MAVS signaling, which bridges MAVS and TRAF3 for an effective antiviral innate immune response.

SUBMITTER: Zhu W 

PROVIDER: S-EPMC6745499 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.

Zhu Wenting W   Li Jiaxin J   Zhang Rui R   Cai Yixiang Y   Wang Changwan C   Qi Shishi S   Chen She S   Liang Xiaozhen X   Qi Nan N   Hou Fajian F  

The EMBO journal 20190807 18


RIG-I-MAVS antiviral signaling represents an important pathway to stimulate interferon production and confer innate immunity to the host. Upon binding to viral RNA and Riplet-mediated polyubiquitination, RIG-I promotes prion-like aggregation and activation of MAVS. MAVS subsequently induces interferon production by activating two signaling pathways mediated by TBK1-IRF3 and IKK-NF-κB respectively. However, the mechanism underlying the activation of MAVS downstream pathways remains elusive. Here,  ...[more]

Similar Datasets

| S-SCDT-EMBOJ-2019-102075 | biostudies-other
| S-EPMC2663242 | biostudies-literature
2024-09-10 | PXD054077 | Pride
| S-EPMC9559812 | biostudies-literature
| S-EPMC6296827 | biostudies-literature
| S-EPMC3932521 | biostudies-literature
| S-EPMC9685455 | biostudies-literature
| S-EPMC10908090 | biostudies-literature
| S-EPMC8137702 | biostudies-literature
| S-EPMC4526786 | biostudies-literature